FDA Green-Lights Drug For People 12 And Older Who Are Exposed To Covid

FDA Green-Lights Drug For People 12 And Older Who Are Exposed To Covid FiercePharma reports on how Shionogi’s oral antiviral drug — sold under the name Xocova and available in Japan since 2022 — has been cleared by the FDA for post-exposure prophylaxis for U.S. adults and some adolescents who have been exposed to covid. This makes it the first post-exposure covid oral drug approved in the United States. https://kffhealthnews.org/morning-breakout/covid/